FVLCX
Price
$19.82
Change
+$0.09 (+0.46%)
Updated
Aug 19 closing price
Net Assets
27.23M
VVIAX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

FVLCX vs VVIAX

Header iconFVLCX vs VVIAX Comparison
Open Charts FVLCX vs VVIAXBanner chart's image
Fidelity Advisor Value Leaders C
Price$19.82
Change+$0.09 (+0.46%)
VolumeN/A
Net Assets27.23M
Vanguard Value Index Adm
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
FVLCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FVLCX vs. VVIAX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVLCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. FVLCX (27.2M). VVIAX pays higher dividends than FVLCX: VVIAX (2.18) vs FVLCX (0.57). FVLCX was incepted earlier than VVIAX: FVLCX (22 years) vs VVIAX (25 years). FVLCX (2.12) is less costly to investors than VVIAX (0.05). FVLCX is a more actively managed with annual turnover of: 32.00 vs. VVIAX (9.00). FVLCX has a lower initial minimum investment than VVIAX: FVLCX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.59 vs. FVLCX (-11.67). VVIAX return over 5 years is better than : 70.19 vs. FVLCX (27.35).
FVLCXVVIAXFVLCX / VVIAX
Total Expense Ratio1.900.053,800%
Annual Report Gross Expense Ratio2.120.054,240%
Fund Existence22 years25 years-
Gain YTD1.7016.53226%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.2M196B0%
Annual Yield % from dividends0.572.1826%
Returns for 1 year-11.677.59-154%
Returns for 3 years-2.9727.03-11%
Returns for 5 years27.3570.1939%
Returns for 10 years29.08127.4523%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRCA6.160.20
+3.27%
Verrica Pharmaceuticals Inc
ARCB71.830.37
+0.52%
ArcBest Corp
FVNNU10.50-0.04
-0.38%
Future Vision II Acquisition Corp.
AM17.55-0.36
-2.01%
Antero Midstream Corp
CAPR7.70-0.27
-3.39%
Capricor Therapeutics